Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: INDA

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • News

‘India antitrust regulator launches probe into Apple App Store payments’ -Apple Insider Report

By Benzinga Newsdesk
Today, 4:16 AM
https://appleinsider.com/articles/21/12/31/india-antitrust-regulator-launches-probe-into-apple-app-store-payments?utm_source=&utm_medium=&utm_campaign=RSS

AAPL

Read More
1 minute read
  • Cryptocurrency
  • Markets
  • News

India Won’t Ban Cryptocurrencies; Securities And Exchange Board Of India To Regulate Them

By Benzinga Newsdesk
Today, 4:16 AM
-Reuters

COIN

Read More
1 minute read
  • Contracts
  • FDA
  • News

India’s Government Has No Plans Yet To Buy Merk’s COVID Pills; Approves 20M Novavax Vaccine Dose Order

By Benzinga Newsdesk
Today, 4:16 AM
-Reuters

INDA

Read More
3 minute read
  • Biotech
  • General
  • Global
  • News

Novavax And Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In Indonesia

By Benzinga Newsdesk
Today, 4:16 AM
Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's

INDA

Read More
1 minute read
  • FDA
  • News

Watching Ocugen Shares; Traders Circulate Thursday Report From Bestinau.net ‘Covaxin can get WHO approval as soon as discussions progress, Shringla says’ Highlighting Comments From India Foreign Minister Harsh Vardhan Shringla

By Benzinga Newsdesk
Today, 4:16 AM
https://bestinau.net/covaxin-can-get-who-approval-as-soon-as-discussions-progress-shringla-says/

INDA

Read More
1 minute read
  • FDA
  • News

‘Secretary, Department of Biotechnology,Govt of India, @RenuSwarup says Bharat Biotech’s Bengaluru facility has started operations, very quickly in a couple of weeks you will see the augmentation of their capacities’ -CNBC-TV18 Tweet

By Benzinga Newsdesk
Today, 4:16 AM
https://twitter.com/CNBCTV18Live/status/1454052163127152642

INDA

Read More
1 minute read
  • General
  • News
  • Politics

Tesla Urges Indian PM Modi’s Office To Slash Import Taxes On EVs; Says Co Has Requested Meeting Between Modi, CEO Elon Musk

By Benzinga Newsdesk
Today, 4:16 AM
-Reuters

INDA

Read More
1 minute read
  • General
  • News
  • Politics

India To Reopen For Tourists Starting Oct. 15

By Benzinga Newsdesk
Today, 4:16 AM
https://twitter.com/AFP/status/1446101684070014977

INDA

Read More
1 minute read
  • Contracts
  • FDA
  • News

‘WHO’s Covaxin Clearance Delayed Further Over Technical Queries: Sources’ -NDTV Report

By Benzinga Newsdesk
Today, 4:16 AM
https://www.ndtv.com/india-news/covaxin-faces-more-delay-for-who-clearance-technical-queries-need-to-be-answered-by-bharat-biotech-sources-2555676

INDA

Read More
1 minute read
  • FDA
  • News

WHO Emergency Use For Covaxin Expected Soon In India

By Benzinga Newsdesk
Today, 4:16 AM
http://toi.in/Uvh3WZ84

INDA

Posts navigation

Previous 1 2 3 4 5 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service